Physician

Robert Joel Welch, MD

According to 2025 Medicare claims, Robert Welch, MD (NPI: 1376981894) practices ophthalmology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is SPOKANE EYE CLINIC PS (NPI: 1730187899; TIN: 910852217) and primary practice location at 99204-2509.

Welch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 686 traditional Medicare patients, billed 46,269 HCPCS/CPT codes, and received $2,584,856 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 636 prescription claims across 159 beneficiaries totaling $20,246 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $26. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,672 to $2,584,856. Similarly, Part D prescription costs have risen steadily, from $1,380 to $20,246. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2018 Medicare payment: $20,672 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $68,950 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $169,642 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,295,085 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,584,979 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,549,900 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,584,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018124190$20,672
2019152413$68,950
20202221,155$169,642
20216186,796$1,295,085
202279913,443$2,584,979
202370732,892$2,549,900
202468646,269$2,584,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$20K2015 Drug cost: $1,380 (USD; Tot_Drug_Cst)2016 Drug cost: $2,246 (USD; Tot_Drug_Cst)2017 Drug cost: $9,509 (USD; Tot_Drug_Cst)2018 Drug cost: $4,171 (USD; Tot_Drug_Cst)2019 Drug cost: $4,756 (USD; Tot_Drug_Cst)2020 Drug cost: $5,221 (USD; Tot_Drug_Cst)2021 Drug cost: $12,782 (USD; Tot_Drug_Cst)2022 Drug cost: $19,448 (USD; Tot_Drug_Cst)2023 Drug cost: $19,113 (USD; Tot_Drug_Cst)2024 Drug cost: $20,246 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151137$1,380
201646161$2,246
2017160541$9,509
201893290$4,171
201941107$4,756
202061160$5,221
2021120370$12,782
2022108412$19,448
2023137559$19,113
2024159636$20,246

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1401,420$651
67028Injection of drug into eye3141,454$91
92014Established patient complete exam of visual system223282$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more165309$64
92134Imaging of retina6742,238$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1897,804$9,272
Atropine SulfateAtropine Sulfate803,083$2,456
Bromfenac SodiumBromfenac Sodium14489$1,894
Ketorolac TromethamineKetorolac Tromethamine472,022$1,027
OfloxacinOfloxacin861,919$1,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$26Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$7,384US Retina LLC

FAQ

What Medicare data is available for Robert Joel Welch, MD?

Tedicare shows public-source Medicare data for Robert Joel Welch, MD (NPI 1376981894), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Joel Welch, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Joel Welch, MD?

Robert Joel Welch, MD is linked to SPOKANE EYE CLINIC PS (billing NPI 1730187899) in the available physician profile data.

Does Robert Joel Welch, MD have Open Payments data?

Robert Joel Welch, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.